Clinical trials
Spondyloarthritis clinical trials
Below are recruiting spondyloarthritis clinical trials, each written for real people, not researchers. We’re tracking 50 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06807853Recruiting
Tracking movement with a smartwatch for spine arthritis
This study uses a smartwatch to track your movement and give you exercise advice. It aims to help people with axial spondyloarthritis stay active and manage their condition.
Bonn, North Rhine-WestphaliaAges 18 years+ - NCT07724847Recruiting
Validating new criteria for diagnosing axial spondyloarthritis
This study aims to confirm new classification criteria for axial spondyloarthritis, a type of inflammatory arthritis affecting the spine and sacroiliac joints. Participants with chronic back pain lasting at least 3 months and starting before age 45 will undergo a series of tests to see if these new criteria better identify the condition.
Beijing, Beijing MunicipalityAges 18–45 - NCT06451588RecruitingPhase 2
Fecal transplant for inflammatory back pain
This study tests whether a fecal microbiota transplant (a procedure that transfers healthy bacteria into your gut) can reduce inflammation and improve symptoms in people with inflammatory back pain (axial spondyloarthritis). It may help if your current treatments are not working well enough.
TromsøAges 18–65 - NCT01277419Recruiting
Study of new cases of several spine, joint, and eye diseases
This study enrolls people who have recently been diagnosed with certain inflammatory conditions affecting the spine, joints, or the eye. Researchers are looking to better understand how these illnesses start and how they may be linked, which could help guide future care.
BerlinAges Any age - NCT03425812Recruiting
NSAID medicines to prevent flares in spondyloarthritis after remission
This trial tests whether taking nonsteroidal anti-inflammatory drugs (NSAIDs) helps people with axial spondyloarthritis stay in remission and avoid future flare-ups. It’s meant to see if NSAIDs can reduce the chance of symptoms returning and keep disease activity low over time.
Xiamen, FujianAges 18 years+ - NCT05781763Recruiting
High-intensity exercise for spondyloarthritis pain and stiffness
This study tests whether a structured, high-intensity exercise program can improve symptoms in people with axial spondyloarthritis. It compares the exercise approach against another group to see if it helps function and well-being.
Halmstad, Halland CountyAges 18–67 - NCT05676775Recruiting
Study for people recently diagnosed with axial spondyloarthritis
This study follows people who were diagnosed with axial spondyloarthritis (axSpA) recently to better understand the condition over time. It’s mainly for adults and teens who can consent and can communicate in English.
LeedsAges 16–50 - NCT07855393Recruiting
Back shape and spine damage in ankylosing spondylitis
This study looks at how the shape of your back relates to spine damage in people with ankylosing spondylitis. It uses a special 3D scanner to measure your back and compares it with your X-rays to see if the scanner can help track the disease.
Ankara, YenimahalleAges 18–65 - NCT05654753RecruitingPhase 2/Phase 3
Fecal transplant for stubborn axial spondyloarthritis
This trial tests whether transplanting healthy stool bacteria (fecal microbiota transplantation) can reduce symptoms in people with axial spondyloarthritis (including ankylosing spondylitis) who are not improving enough with standard medicines. If you qualify, you may receive study capsules containing processed bacteria and be closely monitored for safety and symptom changes.
Boulogne-BillancourtAges 18–75 - NCT07642622Recruiting
Physical Activity Tracking With Wearable Technology for Spine Arthritis
This study tests whether wearing a Fitbit activity tracker and using a Google Health app can help people with axial spondyloarthritis (a type of spine arthritis) become more physically active. The goal is to see if this technology-based approach motivates people to exercise more, which may help reduce pain and improve their condition.
Seattle, WashingtonAges 18 years+ - NCT06112665RecruitingPhase 4
Tofacitinib for early active axial spondyloarthritis
This trial tests whether tofacitinib (a pill that reduces inflammation) can help people with early-stage axial spondyloarthritis, a type of arthritis that mainly affects the spine and pelvis. It's for those who have had symptoms for 2 years or less and have active disease with signs of inflammation in MRI or blood tests.
BerlinAges 18–45 - NCT05290363Recruiting
Studying a blood signal in active spondyloarthritis
This study looks at how a body signal called IL-23 may drive inflammation in spondyloarthritis (including joints) using samples from your care. It may help researchers identify which body cells and targets are involved, and how treatments could work better for active disease.
CréteilAges 18 years+ - NCT06222671RecruitingPhase 2
A study of 608 for non-radiographic axial spondyloarthritis
This study tests a new medicine called 608 for people with non-radiographic axial spondyloarthritis (a type of inflammatory back pain). The goal is to see if it can reduce pain and inflammation.
Beijing, Beijing MunicipalityAges 18 years+ - NCT04853212Recruiting
Study gut microbiome differences in people with spondyloarthritis
This study looks at whether changes in the gut bacteria (called microbiome dysbiosis) are linked to spondyloarthritis. It compares people with the condition to people without it who are already planning a digestive scope for another reason.
Boulogne-BillancourtAges 18 years+ - NCT07133633RecruitingPhase 2
Tulisokibart for X-ray confirmed axial spondyloarthritis
This study tests a new medicine called Tulisokibart for people with a type of inflammatory arthritis that affects the spine and pelvic joints, specifically when X-rays show changes. The goal is to see if it can reduce symptoms like pain and stiffness.
Chandler, ArizonaAges 18–80 - NCT06988813Recruiting
Nanfang Spondyloarthritis Study
This study follows patients with spondyloarthritis over time to better understand the condition. It collects information from hospital visits and may help improve care for people with this type of arthritis.
Guangzhou, GuangdongAges 10–59 - NCT07047703RecruitingPhase 1/Phase 2
Study of an investigational drug for axial spondyloarthritis
This trial tests a new oral medication that may reduce inflammation and improve symptoms in people with axial spondyloarthritis. It is in early phases, meaning the drug is still being studied for safety and effectiveness.
BirtinyaAges 18–65 - NCT04292067Recruiting
Study gut bacteria in people with arthritis
This study compares the gut microbiome (the bacteria in your intestines) in adults with spondyloarthritis or rheumatoid arthritis versus healthy adults. It aims to better describe differences that may help explain these diseases.
Boulogne-BillancourtAges 18 years+ - NCT06860750RecruitingPhase 3
SHR-1314 injection for active non-radiographic axial spondyloarthritis
This trial tests a new injection called SHR-1314 for people with active non-radiographic axial spondyloarthritis (a type of inflammatory arthritis that doesn't show on X-rays but causes back pain and stiffness). It may help reduce inflammation and improve symptoms.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06707194RecruitingPhase 4
Penicillin plus etanercept for spondyloarthritis
This trial tests whether adding a common antibiotic (benzathine penicillin) to a standard biologic drug (etanercept) can better treat spondyloarthritis. It may help if you have active disease and are free of certain infections.
Hefei, AnhuiAges 18–59 - NCT06844643Recruiting
Axial spondyloarthritis progression study in China
This study tracks how axial spondyloarthritis progresses over time in Chinese patients. It helps doctors understand the natural course of the disease and improve care.
BeijingAges 18 years+ - NCT06462937Recruiting
Digital exercise program for recent spondyloarthritis diagnosis
This trial tests a digital exercise program for people newly diagnosed with axial spondyloarthritis (a type of arthritis that affects the spine and joints). If you have active disease, you may join to see if exercise helps manage symptoms.
OsloAges 18 years+ - NCT06454188RecruitingPhase 4
Upadacitinib for Psoriatic Arthritis with Spine Involvement
This study tests how well upadacitinib (a pill taken daily) works for people with active psoriatic arthritis that also affects the spine. It is for those who have not responded well enough to other treatments like NSAIDs or biologics.
Cleveland, OhioAges 18 years+ - NCT06337513Enrolling by invitation
Back pain study for early arthritis diagnosis
This trial looks at people with low back pain to find early signs of a spine arthritis condition. It may help diagnose the condition sooner and guide better treatment.
Sønderborg, Southern DenmarkAges 18–48
Hear when a new Spondyloarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for spondyloarthritis?
- Yes. Clin2 currently lists 50 recruiting spondyloarthritis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a spondyloarthritis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a spondyloarthritis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.